176 related articles for article (PubMed ID: 34342892)
1. Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
Nowakowska MK; Lei X; Thompson MT; Shaitelman SF; Wehner MR; Woodward WA; Giordano SH; Nead KT
Cancer; 2021 Nov; 127(22):4142-4150. PubMed ID: 34342892
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
3. Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.
Wu W; Wu M; Peng G; Shi D; Zhang J
Cancer Med; 2019 Dec; 8(18):7523-7531. PubMed ID: 31642210
[TBL] [Abstract][Full Text] [Related]
4. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
[TBL] [Abstract][Full Text] [Related]
6. Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer.
Emilsson L; García-Albéniz X; Logan RW; Caniglia EC; Kalager M; Hernán MA
JAMA Oncol; 2018 Jan; 4(1):63-70. PubMed ID: 28822996
[TBL] [Abstract][Full Text] [Related]
7. Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women.
Hao S; Liu Y; Yu KD; Chen S; Yang WT; Shao ZM
PLoS One; 2015; 10(6):e0129741. PubMed ID: 26107623
[TBL] [Abstract][Full Text] [Related]
8. Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer.
Li YR; Ro V; Steel L; Carrigan E; Nguyen J; Williams A; So A; Tchou J
Breast Cancer Res Treat; 2019 Aug; 176(3):669-677. PubMed ID: 31087198
[TBL] [Abstract][Full Text] [Related]
9. Statin use and breast cancer risk in a large population-based setting.
Boudreau DM; Yu O; Miglioretti DL; Buist DS; Heckbert SR; Daling JR
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):416-21. PubMed ID: 17372235
[TBL] [Abstract][Full Text] [Related]
10. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
McKechnie T; Brown Z; Lovrics O; Yang S; Kazi T; Eskicioglu C; Parvez E
Clin Breast Cancer; 2024 Apr; 24(3):e103-e115. PubMed ID: 38296737
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.
Yao Y; Chu Y; Xu B; Hu Q; Song Q
Cancer Med; 2019 Feb; 8(2):554-563. PubMed ID: 30632300
[TBL] [Abstract][Full Text] [Related]
13. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Vogel TJ; Goodman MT; Li AJ; Jeon CY
Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
[TBL] [Abstract][Full Text] [Related]
14. The effect of statins on survival in patients with stage IV lung cancer.
Lin JJ; Ezer N; Sigel K; Mhango G; Wisnivesky JP
Lung Cancer; 2016 Sep; 99():137-42. PubMed ID: 27565929
[TBL] [Abstract][Full Text] [Related]
15. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
[TBL] [Abstract][Full Text] [Related]
16. The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer.
Dai L; Cui H; Bao Y; Hu L; Zhou Z; Wang M; Lin S; Wu H; Kang H; Ma X
Cancer Med; 2023 Feb; 12(3):2782-2794. PubMed ID: 36106621
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
18. Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study.
Scott OW; TinTin S; Harborg S; Kuper-Hommel MJJ; Lawrenson R; Elwood JM
Breast Cancer Res Treat; 2023 May; 199(1):195-206. PubMed ID: 36930345
[TBL] [Abstract][Full Text] [Related]
19. Survival in older women with early stage breast cancer receiving low-dose bisphosphonates or denosumab.
Suarez-Almazor ME; Herrera R; Lei X; Chavez-MacGregor M; Zhao H; Giordano SH
Cancer; 2020 Sep; 126(17):3929-3938. PubMed ID: 32573777
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
Polamraju P; Haque W; Cao K; Verma V; Schwartz M; Klimberg VS; Hatch S; Niravath P; Butler EB; Teh BS
Breast; 2020 Feb; 49():8-16. PubMed ID: 31675684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
